Literature DB >> 9728567

Inhibition of neutrophil apoptosis and modulation of the inflammatory response by granulocyte colony-stimulating factor in healthy and ethanol-treated human volunteers.

K Dalhoff1, F Hansen, D Drömann, B Schaaf, S P Aries, J Braun.   

Abstract

Granulocyte colony-stimulating factor (G-CSF) has immunomodulating properties that could be beneficial for adjunctive treatment of severe infections. Cytokine release from stimulated whole blood and expression of neutrophil surface and apoptosis markers in response to G-CSF were studied in human volunteers under physiologic conditions and after ethanol pretreatment. Levels of interleukin (IL)-1 receptor antagonist and soluble tumor necrosis factor (TNF) receptor-1 were significantly increased after G-CSF, whereas TNF-alpha and IL-10 concentrations were reduced, and IL-1beta and IL-8 remained unchanged. There was a significant inhibition of neutrophil apoptosis and increased expression of complement regulatory protein CD55 without changes in CD11b, CD14, and CD59 expression. These effects were well preserved after ethanol pretreatment, which per se led to an increase in apoptosis and decreased CD55 expression. Thus, G-CSF treatment was associated with a reduction of the proinflammatory cytokine response and enhanced neutrophil survival in vivo, suggesting a therapeutic potential of G-CSF for severe infections in the nonneutropenic host.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9728567     DOI: 10.1086/515350

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  G-CSF activation of AKT is not sufficient to prolong neutrophil survival.

Authors:  Liliana R Souza; Erica Silva; Elissa Calloway; Carlos Cabrera; Morgan L McLemore
Journal:  J Leukoc Biol       Date:  2013-04-04       Impact factor: 4.962

2.  Polymorphonuclear leucocytes selectively produce anti-inflammatory interleukin-1 receptor antagonist and chemokines, but fail to produce pro-inflammatory mediators.

Authors:  Anja K Schröder; Maren von der Ohe; Ute Kolling; Julia Altstaedt; Peter Uciechowski; Daniela Fleischer; Klaus Dalhoff; Xinsheng Ju; Martin Zenke; Nicole Heussen; Lothar Rink
Journal:  Immunology       Date:  2006-11       Impact factor: 7.397

3.  Leucocyte response and anti-inflammatory cytokines in community acquired pneumonia.

Authors:  U K Kolling; F Hansen; J Braun; L Rink; H A Katus; K Dalhoff
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

4.  Fas-mediated apoptosis of neutrophils in sera of patients with infection.

Authors:  I E Nwakoby; K Reddy; P Patel; N Shah; S Sharma; M Bhaskaran; N Gibbons; A A Kapasi; P C Singhal
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

Review 5.  Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases.

Authors:  John A Hamilton; Andrew D Cook; Paul P Tak
Journal:  Nat Rev Drug Discov       Date:  2016-12-29       Impact factor: 84.694

6.  Pretreatment with granulocyte colony-stimulating factor attenuates the inflammatory response but not the bacterial load in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits.

Authors:  C Ostergaard; T Benfield; B Gesser; A Kharazmi; N Frimodt-Møller; F Espersen; J D Lundgren
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

7.  Granulocyte-colony stimulating factor drives the in vitro differentiation of human dendritic cells that induce anergy in naïve T cells.

Authors:  Maura Rossetti; Silvia Gregori; Maria Grazia Roncarolo
Journal:  Eur J Immunol       Date:  2010-10-19       Impact factor: 5.532

8.  Triggering receptor expressed on myeloid cells-1 (Trem-1) on blood neutrophils is associated with cytokine inducibility in human E. coli sepsis.

Authors:  Tobias van Bremen; Daniel Drömann; Karin Luitjens; Christoph Dodt; Klaus Dalhoff; Torsten Goldmann; Bernhard Schaaf
Journal:  Diagn Pathol       Date:  2013-02-15       Impact factor: 2.644

9.  Mortality in human sepsis is associated with downregulation of Toll-like receptor 2 and CD14 expression on blood monocytes.

Authors:  Bernhard Schaaf; Karen Luitjens; Torsten Goldmann; Tobias van Bremen; Friedhelm Sayk; Christoph Dodt; Klaus Dalhoff; Daniel Droemann
Journal:  Diagn Pathol       Date:  2009-04-16       Impact factor: 2.644

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.